CML

Showing NaN - NaN of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CML Trial in United States (nilotinib)

Completed
  • CML
  • Birmingham, Alabama
  • +53 more
Feb 25, 2020

AML, CML, MDS Trial in Boston, New York, San Antonio (STA-9090 (ganetespib))

Completed
  • AML
  • +3 more
  • STA-9090 (ganetespib)
  • Boston, Massachusetts
  • +2 more
Sep 17, 2014

AML, CML, MDS Trial in New York (CYT107 - Recombinant glycosylated human interleukin 7., rhIL-7 (CYT107))

Completed
  • AML
  • +2 more
  • CYT107 - Recombinant glycosylated human interleukin 7.
  • rhIL-7 (CYT107)
  • New York, New York
    Memorial Sloan-Kettering Cancer Institute
Jul 25, 2012